Free Trial

Caribou Biosciences (CRBU) Earnings Date, Estimates & Call Transcripts

Caribou Biosciences logo
$2.21
+0.25 (+12.76%)
(As of 11/1/2024 ET)

Caribou Biosciences Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 5Estimated
Actual EPS
(Aug. 6)
-$0.42 Beat By $0.04
Consensus EPS
(Aug. 6)
-$0.46

Caribou Biosciences announced Q2 2024 earnings on August 6, 2024, reporting an EPS of -$0.42, which beat the consensus estimate of -$0.46 by $0.04. Quarterly revenue was reported to be $3.46 million, above analysts' expectations of $3.31 million. With a trailing EPS of -$1.39, Caribou Biosciences' earnings are expected to decrease next year, from ($1.76) to ($2.01) per share.

CRBU Upcoming Earnings

Caribou Biosciences' next earnings date is estimated for Tuesday, November 5, 2024, based off prior year's reporting schedules.

Get Caribou Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Caribou Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CRBU Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRBU Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Caribou Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244-$0.56-$0.35-$0.44
Q2 20244-$0.61-$0.40-$0.48
Q3 20244-$0.67-$0.41-$0.49
Q4 20244-$0.69-$0.45-$0.51
FY 202416-$2.53-$1.61-$1.92
Q1 20251-$0.48-$0.48-$0.48
Q2 20251-$0.49-$0.49-$0.49
Q3 20251-$0.51-$0.51-$0.51
Q4 20251-$0.53-$0.53-$0.53
FY 20254($2.01)($2.01)($2.01)

Caribou Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/5/2024
(Estimated)
------- 
8/6/2024Q2 2024-$0.46-$0.42+$0.04-$0.42$3.31M$3.46M
5/7/2024Q1 2024-$0.39-$0.46 -$0.07-$0.46$3.00M$2.43M  
3/11/2024Q4 2023-$0.22-$0.39 -$0.17-$0.39$5.17M$3.56M  
11/7/2023Q3 2023-$0.38-$0.12+$0.26-$0.12$3.53M$23.66M  
8/8/2023Q2 2023-$0.49-$0.48+$0.01-$0.48$3.45M$3.76M  
5/9/2023Q1 2023-$0.48-$0.46+$0.02-$0.46$3.58M$3.50M  
3/9/2023Q4 2022-$0.47-$0.44+$0.03-$0.44$3.78M$3.69M  
11/8/2022Q3 2022-$0.48-$0.44+$0.04-$0.44$3.63M$3.30M  

Caribou Biosciences Earnings - Frequently Asked Questions

Caribou Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on CRBU's earnings history.

In the previous quarter, Caribou Biosciences (NASDAQ:CRBU) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.04. Learn more on analysts' earnings estimate vs. CRBU's actual earnings.

Caribou Biosciences (NASDAQ:CRBU) has a recorded annual revenue of $34.48 million.

Caribou Biosciences (NASDAQ:CRBU) has a recorded net income of -$102.07 million. CRBU has generated -$1.39 earnings per share over the last four quarters.

Caribou Biosciences's earnings are expected to decrease from ($1.76) per share to ($2.01) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CRBU) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners